6-32974609-C-A
Position:
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP4_StrongBP6_ModerateBP7BS2
The NM_005104.4(BRD2):c.177C>A(p.Ala59=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00309 in 1,614,228 control chromosomes in the GnomAD database, including 29 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0027 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0031 ( 29 hom. )
Consequence
BRD2
NM_005104.4 synonymous
NM_005104.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.331
Genes affected
BRD2 (HGNC:1103): (bromodomain containing 2) This gene encodes a transcriptional regulator that belongs to the BET (bromodomains and extra terminal domain) family of proteins. This protein associates with transcription complexes and with acetylated chromatin during mitosis, and it selectively binds to the acetylated lysine-12 residue of histone H4 via its two bromodomains. The gene maps to the major histocompatability complex (MHC) class II region on chromosome 6p21.3, but sequence comparison suggests that the protein is not involved in the immune response. This gene has been implicated in juvenile myoclonic epilepsy, a common form of epilepsy that becomes apparent in adolescence. Multiple alternatively spliced variants have been described for this gene. [provided by RefSeq, Dec 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -11 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.49).
BP6
Variant 6-32974609-C-A is Benign according to our data. Variant chr6-32974609-C-A is described in ClinVar as [Benign]. Clinvar id is 720050.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr6-32974609-C-A is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-0.331 with no splicing effect.
BS2
High Homozygotes in GnomAdExome4 at 29 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BRD2 | NM_005104.4 | c.177C>A | p.Ala59= | synonymous_variant | 3/13 | ENST00000374825.9 | NP_005095.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BRD2 | ENST00000374825.9 | c.177C>A | p.Ala59= | synonymous_variant | 3/13 | 1 | NM_005104.4 | ENSP00000363958 | P2 |
Frequencies
GnomAD3 genomes AF: 0.00275 AC: 418AN: 152218Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
418
AN:
152218
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00387 AC: 974AN: 251488Hom.: 10 AF XY: 0.00466 AC XY: 633AN XY: 135918
GnomAD3 exomes
AF:
AC:
974
AN:
251488
Hom.:
AF XY:
AC XY:
633
AN XY:
135918
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00313 AC: 4573AN: 1461892Hom.: 29 Cov.: 33 AF XY: 0.00338 AC XY: 2455AN XY: 727248
GnomAD4 exome
AF:
AC:
4573
AN:
1461892
Hom.:
Cov.:
33
AF XY:
AC XY:
2455
AN XY:
727248
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00274 AC: 418AN: 152336Hom.: 0 Cov.: 32 AF XY: 0.00293 AC XY: 218AN XY: 74508
GnomAD4 genome
AF:
AC:
418
AN:
152336
Hom.:
Cov.:
32
AF XY:
AC XY:
218
AN XY:
74508
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
14
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at